<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>同写意 | wechat-feeds</title><link>http://MzA4MzgzMDM5Mg.favicon.privacyhide.com/favicon.ico</link><description>一个以新药创制为核心，汇集国内一流研发精英的大型交流与价值分享平台。“同筑技术人生路，写意中国新药魂”是同写意的初衷与愿景。秉承汇集“一线、一流”，讲求“实用、实在、时效”的原则。</description><managingEditor> (hellodword)</managingEditor><pubDate>Wed, 24 Feb 2021 21:13:28 +0800</pubDate><image><url>http://MzA4MzgzMDM5Mg.favicon.privacyhide.com/favicon.ico</url><title>同写意 | wechat-feeds</title><link>http://MzA4MzgzMDM5Mg.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>多西他赛注射液质量与疗效评价标准的几点考量</title><link>https://mp.weixin.qq.com/s/X700aVFIx-Fqi0Sfsj5o1w</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/CeH9Phpxe2BnS4TLv5SxliaDwWHzxqg0LhZTiaubT2iaI0wCEyhxk3JQicpLVBP6LiaUGBmlERdLkibeW8Uw3ewpukAQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>多西他赛注射液属于胶束制剂，其胶束组分影响活性药物的体内行为。]]></content:encoded><pubDate>Wed, 24 Feb 2021 18:54:17 +0800</pubDate></item><item><title>植德写意丨License In，新药赛道上的加速器（二）</title><link>https://mp.weixin.qq.com/s/VXd2oPuKHitVceVpOXvOZg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/CeH9Phpxe2BnS4TLv5SxliaDwWHzxqg0Lt0bxeYF5IrkRjcdhbwCx7QjRYtQWUz9xaibnHg30C6liarOkfYXt1Qrg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>本篇文章将重点介绍License in协议的价格条款。]]></content:encoded><pubDate>Wed, 24 Feb 2021 18:54:17 +0800</pubDate></item><item><title>FDA加快创新药研发与审评的通道——2020年CDER批准的新药分析</title><link>https://mp.weixin.qq.com/s/Q3JYqh84Jna_P7wn_0gLSA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/CeH9Phpxe2BnS4TLv5SxliaDwWHzxqg0Lg3E6BuSYJxRosJWFbwxpe3QsgwcE4agVXZtV8ibdicIuzvrJ8j1ZsG8A/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>借助加快通道、利用FDA的政策优势，为创新药研发上市提供了捷径。]]></content:encoded><pubDate>Wed, 24 Feb 2021 18:54:17 +0800</pubDate></item><item><title>写意发布丨康希诺生物重组新型冠状病毒疫苗上市申请获NMPA受理</title><link>https://mp.weixin.qq.com/s/yEC3ypX4o726DWuOqAg1Jw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/CeH9Phpxe2BnS4TLv5SxliaDwWHzxqg0LxYNBgVcqldKFpor8hRq31qiaJHX7B3SqhHs0m9WEdwPdbrJZO3jaVRg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>2月24日，重组新型冠状病毒疫苗上市申请获NMPA受理。]]></content:encoded><pubDate>Wed, 24 Feb 2021 18:54:17 +0800</pubDate></item><item><title>细胞信号通路详解之JAK-STAT通路</title><link>https://mp.weixin.qq.com/s/tFXPvVp0PpJ75XCMFhh2FQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/CeH9Phpxe2BnS4TLv5SxliaDwWHzxqg0LvtQCH7ATBmAcuVmojxCbJqRRNibw2bOMGrMq7LrOllWic0kk0Fa6SHsg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>傅新元教授精彩的线上直播内容。]]></content:encoded><pubDate>Wed, 24 Feb 2021 18:54:17 +0800</pubDate></item><item><title>中国新药公司首席医学官（CMO）名录</title><link>https://mp.weixin.qq.com/s/JetyenF63DbTeoLOMUVyOw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/CeH9Phpxe2CZDcd2LUYEvxDic8v2j5mJxDtmsg85YaGyngbUyAXruoqticerxo89ejoZQSH71zGEVichwKBiaP8jTg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>这里汇集了88位首席医学官（CMO）的信息。]]></content:encoded><pubDate>Tue, 23 Feb 2021 21:24:46 +0800</pubDate></item><item><title>关注杜丨单药疗法PD-1抑制剂获FDA批准，治疗晚期NSCLC</title><link>https://mp.weixin.qq.com/s/6LkuoMIFenDQgi0hY_D4aQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/CeH9Phpxe2CZDcd2LUYEvxDic8v2j5mJxF68K034qErDHRtsf8Fc7PcVpma5yDVibYn9hPu1yKBFN5bGRxInCoWw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Libtayo在美国获得第三个批准。]]></content:encoded><pubDate>Tue, 23 Feb 2021 21:24:46 +0800</pubDate></item><item><title>科越医药扩大执行领导团队加入首席业务官，首席医疗官和首席中国区商务官</title><link>https://mp.weixin.qq.com/s/kifc4M0rd_2qYg7HvR8YmQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/CeH9Phpxe2CZDcd2LUYEvxDic8v2j5mJx3LsOfMibiazMKqIfwUGFRnic4lXMXtB8ClEuDCsPhCnMr3icYibDEdDLqsA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>科越医药宣布CMO等新的人士任命。]]></content:encoded><pubDate>Tue, 23 Feb 2021 21:24:46 +0800</pubDate></item><item><title>活动推荐丨HLT&amp; IBM Webinar</title><link>https://mp.weixin.qq.com/s/LpCxhPQlWORd2zp0md2jWg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/CeH9Phpxe2CZDcd2LUYEvxDic8v2j5mJxwnN6K0IFtgOZjctfOgEuQh7vM8Fcl7mHpAusRYbK2AKXia50ssAGMGA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>2021年2月25号。]]></content:encoded><pubDate>Tue, 23 Feb 2021 21:24:46 +0800</pubDate></item><item><title>活动推荐丨相约3月5日新春论坛，聚焦创新药研发</title><link>https://mp.weixin.qq.com/s/b1YQdedKWksOIj1Je57ybg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/CeH9Phpxe2CZDcd2LUYEvxDic8v2j5mJxEKbbsSOpV82icuydyzYcNH6vpleBG6HdCmn12NInm40NV52plUXPu7A/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>3月5日在北大医疗创新谷相约“新春论坛·聚焦创新药研发”。]]></content:encoded><pubDate>Tue, 23 Feb 2021 21:24:46 +0800</pubDate></item><item><title>86位中国新药公司首席医学官大盘点</title><link>https://mp.weixin.qq.com/s/E3ANiXqK3tN2e2HwmSBLtQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/CeH9Phpxe2DA38GQe0D6zp4IpiaHNudF0bJkj601nr2LmHpNzibooJ8dND49q2vWDXZPV0jFtzapWr5lJcX4nqqA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>看看有没有你家的CMO?]]></content:encoded><pubDate>Mon, 22 Feb 2021 18:57:47 +0800</pubDate></item><item><title>肿瘤治疗总任务</title><link>https://mp.weixin.qq.com/s/ep1h1EBwqJWmcUcvYwARAg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/CeH9Phpxe2DA38GQe0D6zp4IpiaHNudF0aickUcclPVzQock79uibRmyWIXCs8OlxL3jOrJYRolrzPPp67GqgFsGA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>肿瘤治疗的核心任务是控制转移肿瘤的发生和增长。]]></content:encoded><pubDate>Mon, 22 Feb 2021 18:57:47 +0800</pubDate></item><item><title>JAK-STAT发现30年：8款产品已上市，国内赛道恒瑞、信达…已布局</title><link>https://mp.weixin.qq.com/s/LemgTjmIxBmRh_Lhcua4rg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/CeH9Phpxe2DA38GQe0D6zp4IpiaHNudF00S6tU37AN8G6VBnzYVKBTKbXn3TKGFghxr1dvBEJufMqx2a73Z0p9Q/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>市场机遇与挑战并存。]]></content:encoded><pubDate>Mon, 22 Feb 2021 18:57:47 +0800</pubDate></item><item><title>同写意丨药明直播间：生物制药系列(七)——基于质谱的生物药结构表征策略与案例分享</title><link>https://mp.weixin.qq.com/s/JJWOv9Pb1-sp45ngjX3hoA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/CeH9Phpxe2DA38GQe0D6zp4IpiaHNudF0I675aELWAPKYhfTP7Xd2VFbGxnsGy69QrIpGKiaO2pZibsh9W97BrACQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>2月25日，15:00-16:00。]]></content:encoded><pubDate>Mon, 22 Feb 2021 18:57:47 +0800</pubDate></item><item><title>流动的新药领袖盛宴，同写意Biotech总裁会客厅</title><link>https://mp.weixin.qq.com/s/iQGditkiwp5trFZXJzHMhQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/CeH9Phpxe2DRmicWic3ic8C9cALclbGibkiczc5Ljj6jfL6tlrrr6fylAS791CiaeLwtib0LPWiblJGTEBmmoxQ35NdsKw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>新药领袖众星闪耀，诗酒豪情激荡，真知灼见频现——是为同写意biotech总裁俱乐部。]]></content:encoded><pubDate>Sun, 21 Feb 2021 17:56:33 +0800</pubDate></item><item><title>创新药也在“内卷”？2021的破局点在哪里？</title><link>https://mp.weixin.qq.com/s/yXr3xaC69sq6NiXoS77N6w</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/CeH9Phpxe2DAxTe0tLZq6aYwUC58Vd18ic0mc9VZh4OEBZRavaKSuvB45xV2hANibGKYsenCWZc3TL8Ga4qVUmiaQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>没有泡沫，就没有创新药。]]></content:encoded><pubDate>Sun, 21 Feb 2021 17:56:33 +0800</pubDate></item><item><title>一文看懂生物类似药</title><link>https://mp.weixin.qq.com/s/Lr9MAXXed9ifRCnAthFINg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/CeH9Phpxe2AqbfYhmvxul9NkMaCFhuzmVytj2icOdEkrpaxZ3JE214zTSlibcJQfuXw4cAicjxyNicZibeR8hSFnmHQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>生物类似药是指与已获准注册的参照药具有相似性的治疗用生物制品。]]></content:encoded><pubDate>Sun, 21 Feb 2021 17:56:33 +0800</pubDate></item><item><title>mRNA疫苗不只是预防新冠，未来会开辟mRNA时代，三位诺奖得主点评mRNA疫苗</title><link>https://mp.weixin.qq.com/s/PGHSW6RpuuvbL11TZMw72g</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/CeH9Phpxe2CVKw7sCqke0eRdbWZe5ySrpxhTslGGoVpf7ALcfTeicPsEUpKUqHkIuXic2WibqdfNGic2yqZCZcmOoQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>有3位诺贝尔奖得主对新冠mRNA疫苗进行了点评。]]></content:encoded><pubDate>Sun, 21 Feb 2021 17:56:33 +0800</pubDate></item><item><title>后卫客串前锋：IO药物扬短避长</title><link>https://mp.weixin.qq.com/s/eyf-zuNCxWygPXDXniuqEg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/CeH9Phpxe2A0H74QNIXHxvdJhicDFolLbNox4Kvr6LEwia6TU6V0jfrrhO9BrOficJO8ZGxYhzHhd5a9zhAaJCavA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>PD-L1抗体与CTLA4抗体联用未能击败标准疗法。]]></content:encoded><pubDate>Sun, 21 Feb 2021 17:56:33 +0800</pubDate></item><item><title>中国医药企协筹备成立“新药研发与注册专业委员会”，程增江将任专委会主任</title><link>https://mp.weixin.qq.com/s/hlNyDSYX5fcsl_UT7jVZGw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/CeH9Phpxe2DAKBLN8DaHDia5NibH7aXbVicXE1kHU0gl1OsY4V9mpITUEXYT0KAudajXdx10ftugRpaBjJsnia31DA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>促进我国医药创新能力提升，营造良好的医药创新生态。]]></content:encoded><pubDate>Sat, 20 Feb 2021 18:47:12 +0800</pubDate></item></channel></rss>